000 | 01876 a2200517 4500 | ||
---|---|---|---|
005 | 20250515151146.0 | ||
264 | 0 | _c20090324 | |
008 | 200903s 0 0 eng d | ||
022 | _a0301-0430 | ||
024 | 7 |
_a10.5414/cnp70475 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeng, A E | |
245 | 0 | 0 |
_aIs treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date? _h[electronic resource] |
260 |
_bClinical nephrology _cDec 2008 |
||
300 |
_a475-84 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcysteine _xadministration & dosage |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aContrast Media _xadverse effects |
650 | 0 | 4 |
_aCoronary Angiography _xadverse effects |
650 | 0 | 4 |
_aCoronary Disease _xdiagnostic imaging |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFree Radical Scavengers _xadministration & dosage |
650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aIopamidol _xadministration & dosage |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aSodium Bicarbonate _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriiodobenzoic Acids _xadministration & dosage |
700 | 1 | _aCellarier, E | |
700 | 1 | _aAublet-Cuvelier, B | |
700 | 1 | _aDecalf, V | |
700 | 1 | _aMotreff, P | |
700 | 1 | _aMarcaggi, X | |
700 | 1 | _aDeteix, P | |
700 | 1 | _aSouweine, B | |
773 | 0 |
_tClinical nephrology _gvol. 70 _gno. 6 _gp. 475-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5414/cnp70475 _zAvailable from publisher's website |
999 |
_c18504322 _d18504322 |